Two new items are under consideration by the Food and Drug Administration (FDA) that could reduce the number of HIV infections:
- Last week, a panel of experts recommended that the FDA approve a pill known as Truvada that could be taken preemptively by healthy but at-risk individuals to prevent the contraction of HIV. The pill is already approved for the treatment of HIV, and the FDA’s final decision about whether to approve it for prevention is expected next month.
- The other advancement awaiting formal approval by the FDA is an over-the-counter HIV test kit, which allows consumers to perform oral HIV tests in the privacy of their homes. The test, which detects antibodies to the virus in saliva, returns results in about 20 minutes. On Tuesday, a 17-member advisory panel unanimously recommended that the FDA approve this kit for over-the-counter-use. While the agency declined to comment on when it will release its final decision, executives for the manufacturer expect a decision sometime this summer.
January 26, 2023
A camel carrying a load. A golden pair of balanced scales. An open heart and an open mind. These are three of more than two dozen artists' visions of justice and righteousness featured in the invitational exhibition, "Tzedek Boxes: Justice Shall You Pursue."
January 25, 2023
Tu BiShvat, the Jewish New Year of the Trees, is upon us. While it may not be the most celebrated new year in the Jewish tradition, there is a simple power to the holiday - the call for us to become attuned to nature and learn what it can teach us about personal growth.